Dose intensity and toxicity associated with Taxotere formulation-Reference-Cited by-同舟云学术

Dose intensity and toxicity associated with Taxotere formulation

Published:2015-10 Issue:9 Volume:26 Page:984-989
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Chanat Cédric,Delbaldo Catherine,Denis Jennifer,Bocaccio François,Cojean-Zelek Isabelle,Le Guyader Nathalie

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference11 articles.

1. Taxanes for adjuvant treatment of early breast cancer.;Ferguson;Cochrane Database Syst Rev,2010

2. . Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer.;Chevallier;J Clin Oncol,1995

3. Controversies in the management of adjuvant breast cancer with taxans: review of the current literature.;Araque Arroyo;Cancer Treat Rev,2011

4. . Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 Trial.;Roche;J Clin Oncol,2006

5. . New formulation Taxotere reduces preparation time and supports the physical stability of the product in infusion bags: data from the RELIUS international observational study.;Pinguet;EJHP Practice,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Post-Marketing Surveillance Study to Evaluate the Safety Profile of AlvotereⓇ (Docetaxel) in Iranian Patients Diagnosed with Different Types of Cancers Receiving Chemotherapy;Current Therapeutic Research;2022

2. Docetaxel loaded mPEG-PLA nanoparticles for sarcoma therapy: preparation, characterization, pharmacokinetics, and anti-tumor efficacy;Drug Delivery;2021-01-01

3. Oestrogen receptor-mediated liposomal drug delivery for treating melanoma;Journal of Drug Targeting;2018-02-07

4. Genetic background influences susceptibility to chemotherapy-induced hematotoxicity;The Pharmacogenomics Journal;2017-06-13

5. A versatile nanoplatform for synergistic combination therapy to treat human esophageal cancer;Acta Pharmacologica Sinica;2017-05-29